Recent blog posts
NCT07728175 Sirolimus Genetic Diseases, Inborn Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07728175 Sirolimus Genetic Diseases, Inborn Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07728175 clinical trial report covering Sirolimus, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07729098 Bevacizumab Hematoma, Subdural, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07729098 Bevacizumab Hematoma, Subdural, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07729098 clinical trial report covering Bevacizumab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07731139 YP-05002 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07731139 YP-05002 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07731139 clinical trial report covering YP-05002, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07732023 HBM7575 Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07732023 HBM7575 Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07732023 clinical trial report covering HBM7575, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262542 HM-2002 Angina Pectoris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262542 HM-2002 Angina Pectoris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262542 clinical trial report covering HM-2002, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07729371 ST-316 Adenomatous Polyposis Coli Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07729371 ST-316 Adenomatous Polyposis Coli Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07729371 clinical trial report covering ST-316, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07731685 Eratrectinib Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07731685 Eratrectinib Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07731685 clinical trial report covering Eratrectinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07732387 Sildenaifl Citrate Erectile Dysfunction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07732387 Sildenaifl Citrate Erectile Dysfunction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07732387 clinical trial report covering Sildenaifl Citrate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07732309 ATG-201 Sjogren's Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07732309 ATG-201 Sjogren's Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07732309 clinical trial report covering ATG-201, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07730190 TQB6426 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07730190 TQB6426 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07730190 clinical trial report covering TQB6426, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07732413 Temozolomide Brain Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07732413 Temozolomide Brain Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07732413 clinical trial report covering Temozolomide, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07729995 LMY-922 Scleroderma, Diffuse Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07729995 LMY-922 Scleroderma, Diffuse Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07729995 clinical trial report covering LMY-922, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →